ORBIMED ADVISORS LLC
Top Portfolio Positions
107 positions ·
$5,411,268,746 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.39% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.03% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.77% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.61% | |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.28% | |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.02% | |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.76% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.62% | |
| AZN |
Astrazeneca PLC
Healthcare
|
670,200 | $132,176,844 | 2.44% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.01% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CCCC
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,252,208 | 856,353 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,683,362 | 1,404,902 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,622,024 | 5,235,146 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,767,329 | 6,830,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,928,480 | 6,830,300 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,760,440 | 4,377,900 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $540,000 | 150,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $855,000 | 150,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $24,954,030 | 4,377,900 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,990,327 | 1,513,058 | Shares | Defined | 2024-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||